Intestinal Disease Clinical Trial
Official title:
Study of the Prevalence of Iron Deficiency in Patients With Chronic Inflammatory Bowel Disease
Despite its known prevalence in IBD, a recent study conducted with Prof. Cacoub (unpublished)
on the national health insurance database showed that iron deficiency was an under-diagnosed
and under-treated co-morbidity. In chronic diseases including IBD, Transferrin Saturation
Factor is only performed in approximately 10% of cases, whereas it is recommended in
inflammatory situations including IBD patients (HAS 2011).
The objective of this study is therefore to obtain updated French data on the prevalence of
iron deficiency in patients with IBD by applying the recommendations of ECCO and French
Health High Authority (determination of ferritinemia and Transferrin Saturation Factor)
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
| Recruiting |
NCT05194527 -
The Detrimental Course of Acute Intestinal Ischemia
|
||
| Recruiting |
NCT04605627 -
The Role of Gut Leakage Markers and Microbiota Signature in Coronary Artery Disease.
|
||
| Enrolling by invitation |
NCT04502784 -
Investigation of Hypophosphataemia Following Intravenous Iron
|
||
| Completed |
NCT03559543 -
Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma
|
Phase 2 | |
| Completed |
NCT03723447 -
Intraoperative TAP Block With Bupivacaine/Dexamethasone Against Liposomal Bupivacaine (Exparel®)
|
Phase 4 | |
| Completed |
NCT04573959 -
Validation of CapsoVision CapsoCam® SV-3 Capsule Endoscopy System
|
N/A | |
| Active, not recruiting |
NCT01236833 -
Lactated Ringer's Solution in Neonates With Feeding Intolerance
|
Phase 2 | |
| Not yet recruiting |
NCT06271538 -
Evaluation of Efficacy of Skål Pro Powder on Symptoms of Irritable Bowel Syndrome
|
Phase 4 | |
| Completed |
NCT02785783 -
Endorings™ Assisted Colonoscopy Versus Standard Colonoscopy for Polyp Detection
|
N/A | |
| Completed |
NCT03012594 -
Lanreotide in the Treatment of Small Bowel Motility Disorders
|
Phase 2 | |
| Recruiting |
NCT06007313 -
Mental Stress and Bowel Preparation Quality
|
||
| Completed |
NCT04982302 -
Gut Microbial Changes After Periodontal Treatment
|
||
| Completed |
NCT03543540 -
Bioequivalence Study of Nexvax2 in Subjects With Celiac Disease
|
Phase 1 | |
| Completed |
NCT03817645 -
Panaceo "MED" for IBS (Irritable Bowel Syndrome)
|
N/A | |
| Completed |
NCT00072943 -
A Humanized Anti-Interferon-γ Monoclonal Antibody (HuZAF) for Moderate to Severe Crohn's Disease
|
Phase 2 | |
| Completed |
NCT03037385 -
Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT03280407 -
NEOadjuvant Chemotherapy Only Compared With Standard Treatment for Locally Advanced Rectal Cancer
|
Phase 2 | |
| Completed |
NCT04263818 -
Endoscopist and Endoscope Motions During Colonoscopy
|
N/A | |
| Recruiting |
NCT05923918 -
A Study to Evaluate Safety and Efficacy of PBK_M2101
|
Phase 3 |